Standard BioTools to Present at 43rd Annual Cowen Health Care Conference
Standard BioTools Inc. (Nasdaq:LAB) announced that President and CEO Michael Egholm, PhD, will present at the Cowen Health Care Conference on March 8, 2023, at 12:50 p.m. ET. The presentation will be available via live webcast on the Investor Relations page of the company’s website. Standard BioTools, previously Fluidigm Corporation, is committed to accelerating breakthroughs in human health through its advanced technologies, including mass cytometry and microfluidics. The company serves a wide range of clients in biomedical research, focusing on oncology, immunology, and other critical areas.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today announced that President and Chief Executive Officer Michael Egholm, PhD, will present at the Cowen Health Care Conference on Wednesday, March 8, 2023, at 12:50 p.m. ET.
The presentation will be webcast live and available on the Investor Relations page of the company’s website at Events & Presentations. A recording of the webcast will be archived and available on the Standard BioTools Investor Relations page at investors.standardbio.com.
About Standard BioTools Inc.
Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at standardbio.com or connect with us on Twitter®, Facebook®, LinkedIn®, and YouTube®. Standard BioTools, the Standard BioTools logo, Fluidigm, the Fluidigm logo and “Unleashing tools to accelerate breakthroughs in human health” are trademarks and/or registered trademarks of Standard BioTools Inc. or its affiliates in the United States and/or other countries. All other trademarks are the sole property of their respective owners. Standard BioTools products are provided for Research Use Only. Not for use in diagnostic procedures.
Investor Contacts:
Scott R. Greenstone, CFA
ir@standardbio.com
Peter DeNardo
415 389 6400
ir@standardbio.com
FAQ
When is the Standard BioTools presentation at the Cowen Health Care Conference?
Who will present at the Cowen Health Care Conference for Standard BioTools?
Where can I watch the Standard BioTools presentation?
What technologies does Standard BioTools focus on?
What is the mission of Standard BioTools?
